FDA Brief

Warning letters Drugs

FDA warning letter to

Guangzhou Minghui Cosmetics Co., Ltd.

High riskIssued Jul 6, 2021Posted Jul 13, 2021Center for Drug Evaluation and Research

Guangzhou Minghui's Qi Yu hand sanitizer gel labeled 75% ethanol tested at 52% and was refused at U.S. border.

What happened

FDA tested a batch of Qi Yu HAND SANITIZER GEL that was detained and refused admission at the U.S. border; the product was labeled to contain 75% ethanol but tested at an average of 52%. After an October 5, 2020 teleconference, FDA said the firm did not provide all requested current good manufacturing practice (CGMP) information, such as assay results and testing methods, and had not initiated a recall as of the letter date. FDA placed all drugs from the firm on Import Alert 66-78 on December 21, 2020, allowing detention without physical examination.

What FDA found

  1. The hand sanitizer contained 52% ethanol although labeled 75%, so its strength was below what it claimed.

    FD&C Act section 501(c), 21 U.S.C. 351(c)
  2. The firm's quality assurance was not working under CGMP, as shown by the subpotency and incomplete responses to FDA requests for testing information.

    FD&C Act section 501(a)(2)(B), 21 U.S.C. 351(a)(2)(B); 21 CFR 211.165
  3. The product was an unapproved new drug because it was not generally recognized as safe and effective and had no approved application, and it did not meet section 505G conditions.

    FD&C Act sections 505(a), 301(d), 505G; 21 U.S.C. 355(a), 331(d), 355h
  4. The label was false or misleading because it said the product contained 75% ethanol when testing found far less.

    FD&C Act section 502(a), 21 U.S.C. 352(a)
  5. The Drug Facts labeling was not prominent and conspicuous as required.

    FD&C Act section 502(c), 21 U.S.C. 352(c); 21 CFR 201.66
  6. The label lacked the required topical warning "If swallowed, get medical help or contact a Poison Control Center right away" and did not give a complete domestic address or phone for serious adverse event reports.

    FD&C Act sections 502(f)(2), 502(x); 21 U.S.C. 352(f)(2), 352(x); 21 CFR 330.1(g)

What FDA wants

FDA asks the firm to respond in writing within 15 working days with corrective actions and prevention, including a detailed investigation of the 52% vs. 75% ethanol finding, a raw material and supplier list, a U.S. shipment and batch reconciliation, and complete batch records; FDA also strongly recommends a qualified CGMP consultant.

Who should pay attention

  • brands or distributors that bought Qi Yu hand sanitizer
  • U.S. consignees, retailers, and importers of hand sanitizer
  • contract manufacturers and importers of OTC hand sanitizers

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Macau-Union Pharmaceutical Limited

    Macau-Union Pharmaceutical failed CGMP and sold unapproved, misbranded Bamboo Pharmacy OTC pain rubs in the U.S.

    High risk
  2. ImprimisRx NJ

    FDA found insanitary sterile compounding and subpotent timolol-latanoprost eye drops at ImprimisRx NJ.

    High risk
  3. Shuzy Rock Inc.

    FDA warns Shuzy Rock Inc. of adulterated hand sanitizers made under insanitary conditions and found below labeled alcohol strength.

    High risk
  4. Guangzhou Zhongkebaishi Health Industry Co., Ltd.

    Guangzhou Zhongkebaishi's Hand Sanitizer Gel, labeled 75% ethanol, tested at 51% and was refused US import.

    High risk